Risk of fetal anomalies with exposure to selective serotonin reuptake inhibitors.
作者信息
Grush L R
出版信息
JAMA. 1998 Jun 17;279(23):1873.
PMID:9634252
Abstract
摘要
相似文献
1
Risk of fetal anomalies with exposure to selective serotonin reuptake inhibitors.暴露于选择性5-羟色胺再摄取抑制剂下胎儿出现异常的风险。
JAMA. 1998 Jun 17;279(23):1873.
2
Anisocoria associated with selective serotonin reuptake inhibitors.与选择性5-羟色胺再摄取抑制剂相关的瞳孔不等大。
BMJ. 1994 Dec 17;309(6969):1620. doi: 10.1136/bmj.309.6969.1620a.
3
Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study.
JAMA. 1998 Feb 25;279(8):609-10. doi: 10.1001/jama.279.8.609.
4
[New antidepressive agents].[新型抗抑郁药]
Union Med Can. 1995 Nov;124(3):8-13.
5
Potential withdrawal syndrome associated with SSRI discontinuation.与停用选择性5-羟色胺再摄取抑制剂（SSRI）相关的潜在戒断综合征。
Ann Pharmacother. 1995 Dec;29(12):1284-85. doi: 10.1177/106002809502901215.
6
Use of serotonin reuptake inhibitors by women of childbearing potential.
JAMA. 1998 Jun 17;279(23):1873-4. doi: 10.1001/jama.279.23.1873-a.
7
[Parkinsonism secondary to the use of sertraline].
Med Clin (Barc). 1995 Dec 8;105(20):797-8.
8
"Impending death" and sertraline.
J Emerg Med. 1995 Mar-Apr;13(2):246. doi: 10.1016/s0736-4679(99)80014-6.
9
Withdrawal syndromes after paroxetine and sertraline discontinuation.帕罗西汀和舍曲林停药后的戒断综合征。
J Clin Psychopharmacol. 1995 Oct;15(5):374-5. doi: 10.1097/00004714-199510000-00012.
10
SIADH in a patient receiving sertraline.
Ann Intern Med. 1995 Nov 15;123(10):811. doi: 10.7326/0003-4819-123-10-199511150-00024.
Zotero 插件